ANGO vs DOW · rev $292.5M vs P/E 74, rev $42.96B
AngioDynamics Inc (ANGO) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Dow Inc (DOW) is a chemicals company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
ANGO currently screens at market cap $378.5M. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the ANGO and DOW stock pages for the full models.
Not investment advice.